T1	chemical 83 98	graphene-coated
T2	disease_or_phenotypic_feature 122 133	sensitivity
T3	chemical 179 189	Metamizole
T4	corrected_disease_or_phenotypic_feature 200 213	kidney injury
T5	disease_or_phenotypic_feature 207 213	injury
T6	disease_or_phenotypic_feature 389 396	obesity
T7	chemical 413 418	lipid
T8	chemical 481 488	Retinal
T9	disease_or_phenotypic_feature 481 503	Retinal Vein Occlusion
T10	chemical 541 548	Retinal
T11	chemical 638 653	Anticoagulation
T12	disease_or_phenotypic_feature 686 705	Atrial Fibrillation
T13	chemical 758 761	ITP
T14	disease_or_phenotypic_feature 758 761	ITP
T15	disease_or_phenotypic_feature 1049 1052	CDC
T16	chemical 1080 1103	emtricitabine-tenofovir
T17	chemical 1080 1123	emtricitabine-tenofovir disoproxil fumarate
T18	chemical 1156 1161	Lipid
T19	chemical 1175 1188	lipid-storage
T20	chemical 1219 1224	lipid
T21	disease_or_phenotypic_feature 1258 1266	diabetes
T22	disease_or_phenotypic_feature 1268 1275	obesity
T23	disease_or_phenotypic_feature 1280 1295	atherosclerosis
T24	chemical 1361 1369	estrogen
T25	chemical 1403 1415	progesterone
T26	disease_or_phenotypic_feature 1472 1485	breast cancer
T27	chemical 1504 1512	Baicalin
T28	disease_or_phenotypic_feature 1523 1533	depression
T29	chemical 1705 1715	carbon-ion
T30	disease_or_phenotypic_feature 1705 1715	carbon-ion
T31	disease_or_phenotypic_feature 1733 1756	head and neck carcinoma
T32	disease_or_phenotypic_feature 1809 1826	pancreatic cancer
T33	disease_or_phenotypic_feature 1846 1863	pancreatic cancer
T34	chemical 1864 1869	group
T35	disease_or_phenotypic_feature 1910 1918	diseases
T36	disease_or_phenotypic_feature 1945 1952	disease
T37	chemical 1953 1958	group
T38	disease_or_phenotypic_feature 1981 2003	Constipation-Relieving
T39	chemical 2016 2026	d-Tagatose
T40	chemical 2099 2113	Apolipoprotein
T41	chemical 2143 2150	Protein
T42	disease_or_phenotypic_feature 2206 2223	Colorectal Cancer
T43	corrected_disease_or_phenotypic_feature 2297 2317	sciatic never injury
T44	disease_or_phenotypic_feature 2311 2317	injury
T45	chemical 2349 2357	molecule
T46	corrected_chemical 2387 2403	PCSK9 inhibitors
T47	chemical 2393 2403	inhibitors
T48	chemical 2426 2431	LDL-C
T49	disease_or_phenotypic_feature 2495 2517	cardiovascular disease
T50	chemical 2551 2559	residual
T51	disease_or_phenotypic_feature 2560 2565	blood
T52	chemical 2612 2619	heparin
T53	chemical 2736 2740	heme
T54	corrected_chemical 2736 2745	heme iron
T55	chemical 2741 2745	iron
T56	chemical 2769 2773	iron
T57	disease_or_phenotypic_feature 2785 2791	cancer
T58	disease_or_phenotypic_feature 2826 2843	colorectal cancer
T59	disease_or_phenotypic_feature 2845 2848	CRC
T60	disease_or_phenotypic_feature 2868 2903	Thrombotic thrombocytopenic purpura
T61	chemical 2905 2908	TTP
T62	disease_or_phenotypic_feature 2905 2908	TTP
T63	disease_or_phenotypic_feature 3067 3087	basal cell carcinoma
T64	disease_or_phenotypic_feature 3088 3092	(BCC
T65	chemical 3136 3144	residual
T66	disease_or_phenotypic_feature 3145 3150	tumor
R1	treats Arg1:T29 Arg2:T31
R2	causes_or_contributes_to Arg1:T56 Arg2:T59
R3	causes_or_contributes_to Arg1:T56 Arg2:T57
R4	causes_or_contributes_to Arg1:T56 Arg2:T58
R5	treats Arg1:T46 Arg2:T49
R6	treats Arg1:T27 Arg2:T28
R7	causes_or_contributes_to Arg1:T20 Arg2:T22
R8	causes_or_contributes_to Arg1:T20 Arg2:T23
R9	causes_or_contributes_to Arg1:T20 Arg2:T21
R10	causes_or_contributes_to Arg1:T3 Arg2:T4
R11	causes_or_contributes_to Arg1:T54 Arg2:T59
R12	causes_or_contributes_to Arg1:T54 Arg2:T57
R13	causes_or_contributes_to Arg1:T54 Arg2:T58
T67	corrected_disease_or_phenotypic_feature 1981 1993	Constipation
R14	treats Arg1:T39 Arg2:T67	
T68	missed_chemical 334 344	medication
R15	causes_or_contributes_to Arg1:T68 Arg2:T4	
T69	missed_disease_or_phenotypic_feature 1669 1698	nasolacrimal duct obstruction
R16	causes_or_contributes_to Arg1:T29 Arg2:T69	
R17	causes_or_contributes_to Arg1:T48 Arg2:T49	
T70	missed_disease_or_phenotypic_feature 2442 2446	T2DM
